Evidence map›Paper›PMID 18771713›Full record

ArticleNeuroscience2008

Differential regulation of prohormone convertase 1/3, prohormone convertase 2 and phosphorylated cyclic-AMP-response element binding protein by short-term and long-term morphine treatment: implications for understanding the "switch" to opiate addiction.

V Paez Espinosa, Y Liu, M Ferrini, A Anghel, Y Nie, P V Tripathi, R Porche, E Jansen, R C Stuart, E A Nillni and 2 more

Open access · greenAbstract read
In one paragraph

Article in Neuroscience, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Activation of CREB in the nucleus accumbens shell produces anhedonia and resistance to extinction of fear in rats.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2011
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

V Paez EspinosaDivision of Endocrinology, Department of Medicine, The Charles Drew University of Medicine & Sciences-UCLA School of Medicine, 1731 East 120th Street, Los Angeles, CA 90059, USA.
Y Liu
M Ferrini
A Anghel
Y Nie
P V Tripathi
R Porche
E Jansen
R C Stuart
E A Nillni
K Lutfy
T C Friedman
Charles R. Drew University of Medicine and Science · USBrown University · USLoma Linda University · USRhode Island Hospital · USUCLA Medical Center · USWestern University of Health Sciences · US

Funding

Sustaining Faculty Development & Community EngagementS21MD000103 · NIMHD · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI CARLISLE, DAVID M · 2001 to 2015
$73.9M
TRANSLATIONAL RESEARCH CORE: DIABETESU54RR014616 · NCRR · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI CASTELLANOS, MANUEL · 1999 to 2009
$15.8M
RESEARCH INFORMATICS COREG12RR003026 · NCRR · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI BAKER, RICHARD S. · 1986 to 2004
$11.5M
Testosterone Action on Muscle Injury and RepairS06GM068510 · NIGMS · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI SINHA HIKIM, AMIYA P · 2003 to 2010
$5.2M
Drew MIDARP (Infrastructure in Drug Abuse Research)R24DA017298 · NIDA · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI FRIEDMAN, THEODORE C · 2004 to 2018
$5.0M
PROTRH GENE TRANSCRIPTION AND BIOSYNTHESIS BY LEPTINR01DK058148 · NIDDK · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI NILLNI, EDUARDO A. · 2000 to 2008
$2.4M
Genes and Proteins Leading to AddictionR01DA014659 · NIDA · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI FRIEDMAN, THEODORE C · 2002 to 2006
$1.1M
ProTRH sorting to the regulated secretory pathwayR01NS045231 · NINDS · RHODE ISLAND HOSPITAL (PROVIDENCE, RI) · PI NILLNI, EDUARDO A · 2003 to 2006
$1.0M
THE OFQ/N/ORL-1 RECEPTOR SYSTEM &COCAINE SENSITIZATIONR01DA016682 · NIDA · WESTERN UNIVERSITY OF HEALTH SCIENCES · PI LUTFY, KABIRULLAH · 2004 to 2006
$513k
The Role of 11beta-HSD1 in Type II Diabetes and ObesityK01DK073272 · NIDDK · CHARLES R. DREW UNIVERSITY OF MED & SCI · PI LIU, YANJUN · 2006 to 2008
$397k
STRUCTURAL DETERMINANTS IN REGULATION OF POMC PROCESSINGK21DA000276 · NIDA · CHARLES R. DREW UNIVERSITY OF MED &SCI · PI FRIEDMAN, THEODORE C · 1995 to 1999
–
NCRR NIH HHS G12 RR003026NCRR NIH HHS G21 RR03026-13NCRR NIH HHS U54 RR014616NCRR NIH HHS U54 RR14616-01NIDA NIH HHS K21 DA000276NIDA NIH HHS K21 DA00276NIDA NIH HHS R01 DA014659NIDA NIH HHS R01 DA016682NIDA NIH HHS R01 DA14659NIDA NIH HHS R24 DA017298NIDA NIH HHS R24DA017298NIDDK NIH HHS K01 DK073272NIDDK NIH HHS R01 DK058148NIDDK NIH HHS R01 DK58148NIGMS NIH HHS S06 GM068510NIMHD NIH HHS S21 MD000103NINDS NIH HHS R01 NS045231
6 · The paper itself

Abstract

Drug addiction is a state of altered brain reward and self-regulation mediated by both neurotransmitter and hormonal systems. Although an organism's internal system attempts to maintain homeostasis when challenged by exogenous opiates and other drugs of abuse, it eventually fails, resulting in the transition from drug use to drug abuse. We propose that the attempted maintenance of hormonal homeostasis is achieved, in part, through alterations in levels of processing enzymes that control the ratio of active hormone to pro-hormone. Two pro-hormone convertases, PC1/3 and PC2 are believed to be responsible for the activation of many neurohormones and expression of these enzymes is dependent on the presence of a cyclic-AMP response element (CRE) in their promoters. Therefore, we studied the effects of short-term (24-h) and long-term (7-day) morphine treatment on the expression of hypothalamic PC1/3 and PC2 and levels of phosphorylated cyclic-AMP-response element binding protein (P-CREB). While short-term morphine exposure down-regulated, long-term morphine exposure up-regulated P-CREB, PC1/3 and PC2 protein levels in the rat hypothalamus as determined by Western blot analysis. Quantitative immunofluorescence studies confirmed these regulatory actions of morphine in the paraventricular and dorsomedial nucleus of the hypothalamus. Specific radioimmunoassays demonstrated that the increase in PC1/3 and PC2 levels following long-term morphine led to increased TRH biosynthesis as evidence by increased TRH/5.4 kDa C-terminal proTRH-derived peptide ratios in the median eminence. Promoter activity experiments in rat somatomammotrope GH3 cells containing the mu-opioid receptor demonstrated that the CRE(s) in the promoter of PC1/3 and PC2 is required for morphine-induced regulation of PC1/3 and PC2. Our data suggest that the regulation of the prohormone processing system by morphine may lead to alterations in the levels of multiple bioactive hormones and may be a compensatory mechanism whereby the organism tries to restore its homeostatic hormonal milieu. The down-regulation of PC1/3, PC2 and P-CREB by short-term morphine and up-regulation by long-term morphine treatment may be a signal mediating the switch from drug use to drug abuse.

Indexed as

AnimalsBehavior, AnimalBody WeightBrainCell Line, TransformedCyclic AMP Response Element-Binding ProteinGene Expression RegulationMaleMorphineNarcoticsPain MeasurementProprotein Convertase 1Proprotein Convertase 2RadioimmunoassayRatsRats, Sprague-DawleyCyclic AMP Response Element-Binding ProteinMorphineNarcoticsProprotein Convertase 1Proprotein Convertase 2Thyrotropin-Releasing Hormone

Identifiers

PMID18771713
PMCPMC2596639
OpenAlexW2093932952

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.